Second annual patient summit promotes collaboration to improve patient care

Mar 23, 2016
Second annual patient summit promotes collaboration to improve patient care

Astellas is excited to host its second annual patient advocacy summit in Washington, D.C. on April 5.

The summit will bring together a variety of patient advocacy leaders, experts working to influence the evolution of health care in the U.S. and Canada, and senior Astellas executives to discuss some of the pressing issues confronting medical innovation and patient access to quality care.

The event, entitled Change Together: Partnering to Improve Patients’ Lives, will delve into key topics specific to quality and coordination of care. This overarching theme is an area of sustained interest for Astellas as evidenced by the recent company sponsorship of the From Volume to Value: Designing a Patient-Centered Healthcare System event. In late January/early February, Astellas teamed up with The Hill to host a three-week forum that brought together health care leaders to discuss the shift from volume to value-based care and enhanced coordination in treating and preventing chronic disease. The effort included a live event in Washington, DC on February 2.

Building on this theme, the April 5 summit will feature discussions on ways to achieve better health outcomes during a time of rapid change, explore how to best incorporate the patient voice into emerging value frameworks, share best practices in patient advocacy and provide insights into Astellas’ approach to innovation from pipeline to community to patient.

“One of the things that really resonated for participants at last year’s summit was the opportunity to meet advocates from other disease and focus areas,” said Margaret Long, Astellas US LLC vice president, Business Communications and Stakeholder Engagement. “We’re approaching this year’s event as a further opportunity to expand our shared network of individuals passionate about improving patient health, through substantive discussions regarding pressing policy issues and shared challenges as well as the opportunity to see old friends and meet new ones.”

Second annual patient summit promotes collaboration to improve patient care

Karl Uhlendorf is director of communications and stakeholder engagement at Astellas Pharma US, Inc. With a 20-year track record of leading diverse public affairs and editorial teams, he currently oversees Astellas’ government communications and stakeholder engagement program.

Prior to joining Astellas in 2014, Karl was vice president of communications and public affairs at the Pharmaceutical Research & Manufacturers of America (PhRMA), responsible for communications strategy and execution in support of the association’s federal and state advocacy priorities. During his eight years at PhRMA, he assumed roles of increasing responsibility and scope.

Prior to joining PhRMA, Karl was editorial director at FDC Reports/Elsevier Business Intelligence, publisher of “The Pink Sheet” and other leading trade publications dedicated to FDA-regulated industries. He began his career as a reporter covering biomedical research and health policy, parlaying the experience into a series of editorial leadership positions.

Karl is actively engaged with a wide array of health-related organizations, including PhRMA, the Biotechnology Innovation Organization, National Pharmaceutical Council, National Consumers League, HealthyWomen, WomenHeart, Research!America and Caregivers Action Network. He graduated with a Bachelor of Literature degree from Bates College in Lewiston, Maine.

Leave a Reply